VPIM
CLYM

Vanguard Personalized Indexing Management’s Climb Bio CLYM Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76.7K Buy
11,204
+77
+0.7% +$444 ﹤0.01% 1992
2025
Q4 		$44.5K Sell
11,127
-3,419
-24% -$8.21K ﹤0.01% 1894
2025
Q3 		$29.2K Buy
+14,546
New +$27K ﹤0.01% 1950
2025
Q2 		– Sell
-15,225
Closed -$18.6K – 2046
2025
Q1 		$18.6K Buy
+15,225
New +$24.7K ﹤0.01% 1780

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Vanguard Personalized Indexing Management's CLYM Position: Q1 2026 in Review

Vanguard Personalized Indexing Management increased its Climb Bio (CLYM) stake by 0.69% in Q1 2026, buying an estimated $444 and bringing the position to 11,204 shares worth $76.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1992.

Vanguard Personalized Indexing Management first reported a position in CLYM in Q1 2025 and has held it in 4 quarters since. 80 funds tracked by Wall St. Rank hold CLYM as of Q1 2026.

  • Vanguard Personalized Indexing Management held 11,204 shares of Climb Bio worth $76.7K as of Q1 2026.
  • Vanguard Personalized Indexing Management bought 77 Climb Bio shares in Q1 2026, an estimated $444.
  • Climb Bio made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #1992 holding.
  • Vanguard Personalized Indexing Management first reported a position in Climb Bio in Q1 2025 and has held it in 4 quarters since.
  • 80 funds tracked by Wall St. Rank held Climb Bio as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.